The newly formed Integrated Biology Solutions unit will reside within Agilent's Life Sciences and Chemical Analysis business group. Fran DiNuzzo, vice president of the bio-reagents, consumables, and services, will oversee the new division, Agilent said.
The unit, modeled on the systems biology approach, will "provide a single interface through which Agilent can better serve its customers in basic research, drug discovery and early-stage drug development," said DiNuzzo, whose new title is vice president and general manager of IBS. He also said the division will "enable" Agilent to better develop new products "that bridge multiple disciplines."
Christina Maehr, a spokeswoman for Agilent, told GenomeWeb News that the company has no current plans to eliminate any positions. "This move is not an attempt to cut back" on spending, she said. Additionally, she said the company is "hiring for several positions," including industry marketing manager.